Sign In
Buy ABEO
$6.42
-0.0500 (-0.773%)
At Close: Jul 31, 2026
3 Biotech Stocks That Soared This Week: Are They Buys?
12:34pm, Saturday, 22'nd Feb 2020
Can these high-flying biotech stocks keep up their sizzling momentum?
The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis
Feb 21, 2020 (The Expresswire) --
EV On-Board Chargers market report includes all the factors that will affect the market trends, drivers and challenges of...
US Dollar Flexes Muscles Against Other Currencies: 5 Winners
12:03pm, Thursday, 20'th Feb 2020
The US dollar drew support from a healthy domestic economy, and Fed's cautiously optimistic stance about holding interest rates despite the coronavirus outbreak.
Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™
07:15pm, Wednesday, 12'th Feb 2020
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced that researchers from the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospi
Investment Analysts' Updated EPS Estimates for February, 11th (ABEO, AEG, AER, AGI, AHH, AIN, ALPMY, AMCRY, AMRX, AMSC)
10:38pm, Tuesday, 11'th Feb 2020
Investment Analysts’ updated eps estimates for Tuesday, February 11th: Abeona Therapeutics (NASDAQ:ABEO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The
Casinos, Airlines Tumble as Hong Kong Stocks Resume in Punishing Fashion
02:10pm, Wednesday, 29'th Jan 2020
The coronavirus outbreak from Wuhan has hit Hong Kong stocks hard as they resume trade. We won't know the impact on mainland listings until next week at the earliest.
Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa
01:00pm, Tuesday, 21'st Jan 2020
NEW YORK and CLEVELAND, Jan. 21, 2020 -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced its participation in the.
Abeona Therapeutics Announces Issuance of U.S. Patent for AIM™ Capsids
02:33pm, Wednesday, 15'th Jan 2020
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced that the United States Patent and Trademark Office (USPTO) issued a patent covering next-generation
Les inscriptions à l'étude sont ouvertes et la sélection des patients est en cours à l'Université de Stanford La société s'attend à ce qu'un premier...
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced that it has received Institutional Review Board (IRB) approval from Stanford University to commence
Investors who purchased the Company's securities between May 31, 2018 and September 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 2, 2020. You can also
NEW YORK, NY / ACCESSWIRE / January 2, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Abeona Therapeutics Inc. ("Abeona" or "the ...
A Base Editing IPO from Beam Therapeutics
05:59am, Tuesday, 01'st Oct 2019
The ability to modify genes may be one of the most promising disruptive technologies there is today. As the general public learns about the potential of gene editing, retail investors will be looki
Boy with skin disease who said I've had enough of life gets 18000 birthday cards
05:15pm, Friday, 20'th Sep 2019
Thousands of kind-hearted well-wishers were moved by the challenges faced by Rhys Williams, who lives with rare skin condition epidermolysis bullosa.
